"The most overhyped part is the assumption that pet obesity drugs will replicate the human GLP-1 market in terms of penetration and pricing," he said, noting that veterinary medicine remains largely an out-of-pocket expense for owners and that affordability will likely constrain uptake
These issues seem to arise from common side effects such as dehydration, acid reflux, and vomiting, according to Dr
Working with a reputable pharmacy that's transparent about its sourcing and formulation helps ensure you're on solid ground regardless of how the regulatory situation evolves
Clinical studies have shown that Ozempic can help individuals lose about 10-15% of their body weight when combined with healthy lifestyle changes
This may reduce the financial incentive for market entry, potentially producing fewer entrants than the drugs revenue history would predict
Take away message: 1) Just over half discontinued both drugs 2) The proportions achieving at least 5%, 10%, and 15% weight loss within 1 year with tirzepatide vs semaglutide were 81.8% vs 66.5%, 62.1% vs 37.1%, and 42.3% vs 18.1%, respectively
